Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,655 | -39,025 | -45,617 | -35,170 | -17,711 |
| Income taxes - deferred | N/A | N/A | 5 | N/A | N/A |
| Accounts payable and accrued liabilities | -5,981 | N/A | 6,724 | N/A | 2,120 |
| Other Working Capital | -7,988 | -4,374 | 7,652 | 2,994 | 1,704 |
| Other Operating Activity | 39,335 | 20,787 | -31,105 | -16,074 | -19,886 |
| Operating Cash Flow | $-45,289 | $-22,612 | $-62,341 | $-48,250 | $-33,773 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,193 | 5,956 | 10,793 | 31,255 | 18,850 |
| Investing Cash Flow | $29,193 | $5,956 | $10,793 | $31,255 | $18,850 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 91 | N/A | 53,807 | 115 | 115 |
| Financing Cash Flow | $91 | $N/A | $53,807 | $115 | $115 |
| Beginning Cash Position | 22,808 | 22,808 | 20,549 | 20,549 | 20,549 |
| End Cash Position | 6,803 | 6,152 | 22,808 | 3,669 | 5,741 |
| Net Cash Flow | $-16,005 | $-16,656 | $2,259 | $-16,880 | $-14,808 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,289 | -22,612 | -62,341 | -48,250 | -33,773 |
| Free Cash Flow | -45,289 | -22,612 | -62,341 | -48,250 | -33,773 |